Showing results (311-320 of 434) with videos related to
Sort By:
Pageof 44
Plos One|January 28, 2014
In vivo measurement of hippocampal GABAA/cBZR density with [18F]-flumazenil PET for the study of disease progression in an animal model of temporal lobe epilepsyLucy Vivash, Marie-Claude Gregoire, Viviane Bouilleret, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2018
Prospective, Multisite, International Comparison of 18F-Fluoromethylcholine PET/CT, Multiparametric MRI, and 68Ga-HBED-CC PSMA-11 PET/CT in Men with High-Risk Features and Biochemical Failure After Radical Prostatectomy: Clinical Performance and Patient OutcomesLouise Emmett, Ur Metser, Glenn Bauman, et al.European Journal of Nuclear Medicine and Molecular Imaging|June 13, 2019
Characteristics and outcomes of therapy-related myeloid neoplasms after peptide receptor radionuclide/chemoradionuclide therapy (PRRT/PRCRT) for metastatic neuroendocrine neoplasia: a single-institution seriesIsaac Goncalves, Kate Burbury, Michael Michael, et al.AJR. American Journal of Roentgenology|July 15, 2026
Optimal Imaging Strategies After Negative PSMA PET/CT Results in Patients With Prostate Cancer Biochemical Recurrence: AJR Expert Panel Narrative ReviewWonkyu P Choi, Frankis G Almaguel, Elisa Franquet-Elia, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 17, 2013
18F-flumazenil: a γ-aminobutyric acid A-specific PET radiotracer for the localization of drug-resistant temporal lobe epilepsyLucy Vivash, Marie-Claude Gregoire, Eddie W Lau, et al.Molecular Imaging and Biology|June 19, 2025
Poor Diagnostic Performance of the Melanin-Binding Tracer [18 F]MEL050 in Human Melanoma Indicates Biological HeterogeneityRobert E Ware, Damien Kee, Peter Roselt, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 17, 2020
Therapeutic Efficacy of a Bivalent Inhibitor of Prostate-Specific Membrane Antigen Labeled with 67CuLachlan E McInnes, Carleen Cullinane, Peter D Roselt, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 21, 2006
A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancerTrevor Leong, Craig Everitt, Kally Yuen, et al.NPJ Precision Oncology|April 8, 2022
Imaging immunity in patients with cancer using positron emission tomographyFiona Hegi-Johnson, Stacey Rudd, Rodney J Hicks, et al.European Journal of Nuclear Medicine and Molecular Imaging|February 12, 2009
In-vivo imaging characteristics of two fluorinated flumazenil radiotracers in the ratStefanie Dedeurwaerdere, Marie-Claude Gregoire, Lucy Vivash, et al.Pageof 44